Literature DB >> 1262440

Triiodothyronine (T3)-binding immunoglobulins in a euthyroid woman: effects on measurement of T3 (RIA) and on T3 turnover.

S Y Wu, W L Green.   

Abstract

A 36-year-old woman with nodular goiter, nervousness, and tachycardia was evaluated for T3 toxicosis. Her serum thyroxine level, resin T3 uptake, and thyroidal radioiodine uptake were normal. Her T3 (RIA), by a technique employing charcoal to separate bound and free T3, was reported as indeterminate due to an interfering substance; by a double-antibody method, her T3 (RIA) was 325 ng/dl. Further studies of the patient's serum revealed an abnormal T3-binding protein which misgrated in the beta-gamma globulin zone on paper electrophoresis and gel filtration chromatography (Sephadex G-200), and was precipitated from serum by rabbit anti-human Fab antibody. The gamma globulin fraction of the patient's serum, separated by a standard technique, showed strong binding activity toward [125I]T3, with an association constant of 4.1 X 10(8) 1/mole (Scatchard plot). In a similar system, labeled T4 was not bound. To avoid artefacts which this T3-binding protein might produce in assaying unextracted serum, T3 (RIA) was performed on an ethanol extract of serum and found to be 191 ng/dl, a slight elevation. However, the metabolic clearance rate of injected [125I]T3, estimated by non-compartmental analysis of the serum decay curve or by the specific activity or urinary T3, was about 16 1/day, a low value, so that the T3 production rate, 31 mug/day, was normal. The patient's symptoms disappeared with the resolution of domestic problems, and she appeared clinically euthyroid. Serum TSH was 5.0 uU/ml and antithyroglobulin titer, 1:16. A test for antibodies to thyroid microsomes was negative. We postulate that this subject was euthyroid, but had a concentration of T3-binding immunoglobulin which was sufficient to produce modest slowing of T3 turnover, borderline elevation of extractable T3 (RIA), and a major artefact in the T3 (RIA) measurement of unextracted serum. A similar abnormality may account for other instances of high T3:T4 ratios in serum.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262440     DOI: 10.1210/jcem-42-4-642

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes.

Authors:  Melvin E Klegerman; Shaoling Huang; Devang Parikh; Janet Martinez; Sasha M Demos; Hayat A Onyuksel; David D McPherson
Journal:  Biochim Biophys Acta       Date:  2007-04-14

2.  Interference of anti-T3 autoantibodies in the measurement of total and free T3 in serum.

Authors:  R Abraham; R Chawla
Journal:  Indian J Clin Biochem       Date:  1997-12

Review 3.  Circulating thyroid hormone autoantibodies.

Authors:  S Benvenga; F Trimarchi; J Robbins
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

Review 4.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

5.  Identification and characterization of circulating thyroid hormone autoantibodies in thyroid diseases, in autoimmune non thyroid illnesses and in lymphoreticular system disorders.

Authors:  F Trimarchi; S Benvenga; G Costante; C Barbera; R Melluso; C Marcocci; L Chiovato; F De Luca; F Consolo
Journal:  J Endocrinol Invest       Date:  1983-06       Impact factor: 4.256

6.  Anti-iodothyronine autoantibodies in a girl with hyperthyroidism due to pituitary resistance to thyroid hormones.

Authors:  A Crinò; P Borrelli; R Salvatori; D Cortelazzi; R Roncoroni; P Beck-Peccoz
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

7.  A quick method to detect circulating anti-thyroid hormone autoantibodies.

Authors:  S Savastano; A P Tommaselli; R Valentino; M Carlino; A Selleri; G Randazzo; S Benvenga; G Lombardi
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

8.  Antibody binding serum T3 in a patient with hepatocarcinoma.

Authors:  J Ordóñez-Llanos; J Rodríguez-Espinosa; J A Gómez-Gerique
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

9.  Circulating antitriiodothyronine autoantibodies in two euthyroid patients: apparent lack of interference in total T3 radioimmunoassay based on second antibody or solid phase separation techniques.

Authors:  P Beck-Peccoz; P B Romelli; G Faglia
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

10.  False elevation of serum thyroxine in myxoedema due to thyroxine-binding autoantibodies. A diagnostic pitfall.

Authors:  G P Archbold; H J Southgate; J D Teale; V Marks
Journal:  Ulster Med J       Date:  1986-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.